LYBALVI
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for LYBALVI, covering 2021-05-28 to 2026-01-30. Get the full timeline:
Most recent: FDA Approved: LYBALVI — Supplemental Application (Alkermes, Inc.)
6 regulatory and trial events tracked for LYBALVI, covering 2021-05-28 to 2026-01-30. Get the full timeline:
Most recent: FDA Approved: LYBALVI — Supplemental Application (Alkermes, Inc.)